Thrombolytic Therapy Market in UK - Industry Outlook and Forecast 2020-2026

April 2020 | 90 pages | ID: T80891656EEEEN
Market Monitor Global

Abstracts

The thrombolytic therapy market covers drug treatment, surgical treatment, etc. The typical players include Roche, Taj Pharmaceuticals, Genentech, etc.

This report contains market size and forecasts of Thrombolytic Therapy in UK, including the following market information:
UK Thrombolytic Therapy Market Revenue, 2015-2020, 2021-2026, ($ millions)

Top Five Competitors in UK Thrombolytic Therapy Market 2019 (%)
The global Thrombolytic Therapy market was valued at 32090 million in 2019 and is projected to reach US$ 34740 million by 2026, at a CAGR of 2.0% during the forecast period. While the Thrombolytic Therapy market size in UK was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.

COVID-19 pandemic has big impact on Thrombolytic Therapy businesses, with lots of challenges and uncertainty faced by many players of Thrombolytic Therapy in UK.
This report also analyses and evaluates the COVID-19 impact on Thrombolytic Therapy market size in 2020 and the next few years in UK

Total Market by Segment:

UK Thrombolytic Therapy Market, By Type, 2015-2020, 2021-2026 ($ millions)
UK Thrombolytic Therapy Market Segment Percentages, By Type, 2019 (%)

• Drug Treatment
• Surgical Treatment
• Other Treatment
• Drug treatment is the most commonly used type, with about 89.15% market share in 2019.

UK Thrombolytic Therapy Market, By Application, 2015-2020, 2021-2026 ($ millions)
UK Thrombolytic Therapy Market Segment Percentages, By Application, 2019 (%)

• Acute Myocardial Infarction
• Pulmonary Embolism
• Deep Vein Thrombosis
• Blocking the Catheter
• Acute Ischemic Stroke
• Demand from the acute myocardial infarction accounts for the largest market share, being 36.9% in 2019.

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Thrombolytic Therapy Market Competitors Revenues in UK, by Players 2015-2020 (Estimated), ($ millions)
Total Thrombolytic Therapy Market Competitors Revenues Share in UK, by Players 2019 (%)
Further, the report presents profiles of competitors in the market, including the following:

• Roche
• Boehringer Ingelheim
• Mochida Pharmaceutical
• NanJing Nanda Pharmaceutical
• Wanhua Biochem
• Tianjin Biochem Pharmaceutical
• Livzon Pharmaceutical Group
• Sedico Pharmaceuticals
• Microbix

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Thrombolytic Therapy Market Definition
1.2 Market Segments
  1.2.1 Segment by Type
  1.2.2 Segment by Application
1.3 COVID-19 Impact: UK Thrombolytic Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 UK THROMBOLYTIC THERAPY OVERALL MARKET SIZE

2.1 UK Thrombolytic Therapy Market Size: 2020 VS 2026
2.2 UK Thrombolytic Therapy Revenue, Prospects & Forecasts: 2015-2026

3 COMPANY LANDSCAPE

3.1 Top Thrombolytic Therapy Players in UK (including Foreign and Local Companies)
3.2 Top UK Thrombolytic Therapy Companies Ranked by Revenue
3.3 UK Thrombolytic Therapy Revenue by Companies (including Foreign and Local Companies)
3.4 Top 3 and Top 5 Thrombolytic Therapy Companies in UK, by Revenue in 2019
3.5 UK Manufacturers Thrombolytic Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Thrombolytic Therapy Players in UK
  3.6.1 List of UK Tier 1 Thrombolytic Therapy Companies
  3.6.2 List of UK Tier 2 and Tier 3 Thrombolytic Therapy Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - UK Thrombolytic Therapy Market Size Markets, 2020 & 2026
  4.1.2 Drug Treatment
  4.1.3 Surgical Treatment
  4.1.4 Other Treatment
4.2 By Type - UK Thrombolytic Therapy Revenue & Forecasts
  4.2.1 By Type - UK Thrombolytic Therapy Revenue, 2015-2020
  4.2.2 By Type - UK Thrombolytic Therapy Revenue, 2021-2026
  4.2.3 By Type - UK Thrombolytic Therapy Revenue Market Share, 2015-2026

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - UK Thrombolytic Therapy Market Size, 2020 & 2026
  5.1.2 Acute Myocardial Infarction
  5.1.3 Pulmonary Embolism
  5.1.4 Deep Vein Thrombosis
  5.1.5 Blocking the Catheter
  5.1.6 Acute Ischemic Stroke
5.2 By Application - UK Thrombolytic Therapy Revenue & Forecasts
  5.2.1 By Application - UK Thrombolytic Therapy Revenue, 2015-2020
  5.2.2 By Application - UK Thrombolytic Therapy Revenue, 2021-2026
  5.2.3 By Application - UK Thrombolytic Therapy Revenue Market Share, 2015-2026

6 PLAYERS PROFILES

6.1 Roche
  6.1.1 Roche Corporate Summary
  6.1.2 Roche Business Overview
  6.1.3 Roche Thrombolytic Therapy Major Product Offerings
  6.1.4 Roche Revenue in UK (2015-2020)
  6.1.5 Roche Key News
6.2 Boehringer Ingelheim
  6.2.1 Boehringer Ingelheim Corporate Summary
  6.2.2 Boehringer Ingelheim Business Overview
  6.2.3 Boehringer Ingelheim Thrombolytic Therapy Major Product Offerings
  6.2.4 Boehringer Ingelheim Revenue in UK (2015-2020)
  6.2.5 Boehringer Ingelheim Key News
6.3 Mochida Pharmaceutical
  6.3.1 Mochida Pharmaceutical Corporate Summary
  6.3.2 Mochida Pharmaceutical Business Overview
  6.3.3 Mochida Pharmaceutical Thrombolytic Therapy Major Product Offerings
  6.3.4 Mochida Pharmaceutical Revenue in UK (2015-2020)
  6.3.5 Mochida Pharmaceutical Key News
6.4 NanJing Nanda Pharmaceutical
  6.4.1 NanJing Nanda Pharmaceutical Corporate Summary
  6.4.2 NanJing Nanda Pharmaceutical Business Overview
  6.4.3 NanJing Nanda Pharmaceutical Thrombolytic Therapy Major Product Offerings
  6.4.4 NanJing Nanda Pharmaceutical Revenue in UK (2015-2020)
  6.4.5 NanJing Nanda Pharmaceutical Key News
6.5 Wanhua Biochem
  6.5.1 Wanhua Biochem Corporate Summary
  6.5.2 Wanhua Biochem Business Overview
  6.5.3 Wanhua Biochem Thrombolytic Therapy Major Product Offerings
  6.5.4 Wanhua Biochem Revenue in UK (2015-2020)
  6.5.5 Wanhua Biochem Key News
6.6 Tianjin Biochem Pharmaceutical
  6.6.1 Tianjin Biochem Pharmaceutical Corporate Summary
  6.6.2 Tianjin Biochem Pharmaceutical Business Overview
  6.6.3 Tianjin Biochem Pharmaceutical Thrombolytic Therapy Major Product Offerings
  6.6.4 Tianjin Biochem Pharmaceutical Revenue in UK (2015-2020)
  6.6.5 Tianjin Biochem Pharmaceutical Key News
6.7 Livzon Pharmaceutical Group
  6.6.1 Livzon Pharmaceutical Group Corporate Summary
  6.6.2 Livzon Pharmaceutical Group Business Overview
  6.6.3 Livzon Pharmaceutical Group Thrombolytic Therapy Major Product Offerings
  6.4.4 Livzon Pharmaceutical Group Revenue in UK (2015-2020)
  6.7.5 Livzon Pharmaceutical Group Key News
6.8 Sedico Pharmaceuticals
  6.8.1 Sedico Pharmaceuticals Corporate Summary
  6.8.2 Sedico Pharmaceuticals Business Overview
  6.8.3 Sedico Pharmaceuticals Thrombolytic Therapy Major Product Offerings
  6.8.4 Sedico Pharmaceuticals Revenue in UK (2015-2020)
  6.8.5 Sedico Pharmaceuticals Key News
6.9 Microbix
  6.9.1 Microbix Corporate Summary
  6.9.2 Microbix Business Overview
  6.9.3 Microbix Thrombolytic Therapy Major Product Offerings
  6.9.4 Microbix Revenue in UK (2015-2020)
  6.9.5 Microbix Key News
6.10 Syner-Med
  6.10.1 Syner-Med Corporate Summary
  6.10.2 Syner-Med Business Overview
  6.10.3 Syner-Med Thrombolytic Therapy Major Product Offerings
  6.10.4 Syner-Med Revenue in UK (2015-2020)
  6.10.5 Syner-Med Key News

7 KEY MARKET TRENDS & INFLUENCES 2021-2026

7.1 PESTLE Analysis for UK Thrombolytic Therapy Market
7.2 Market Opportunities & Trends
7.3 Market Drivers
7.4 Market Restraints

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Thrombolytic Therapy in UK
Table 2. Top Players in UK, Ranking by Revenue (2019)
Table 3. UK Thrombolytic Therapy Revenue by Companies, (US$, Mn), 2015-2020
Table 4. UK Thrombolytic Therapy Revenue Share by Companies, 2015-2020
Table 5. UK Thrombolytic Therapy Sales by Companies, (K Units), 2015-2020
Table 6. UK Thrombolytic Therapy Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Thrombolytic Therapy Price (2015-2020) (US$/Unit)
Table 8. UK Manufacturers Thrombolytic Therapy Product Type
Table 9. List of UK Tier 1 Thrombolytic Therapy Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of UK Tier 2 and Tier 3 Thrombolytic Therapy Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Thrombolytic Therapy Revenue in UK (US$, Mn), 2015-2020
Table 12. By Type - Thrombolytic Therapy Revenue in UK (US$, Mn), 2021-2026
Table 13. By Type - Thrombolytic Therapy Sales in UK (K Units), 2015-2020
Table 14. By Type - Thrombolytic Therapy Sales in UK (K Units), 2021-2026
Table 15. By Application - Thrombolytic Therapy Revenue in UK, (US$, Mn), 2015-2020
Table 16. By Application - Thrombolytic Therapy Revenue in UK, (US$, Mn), 2021-2026
Table 17. By Application - Thrombolytic Therapy Sales in UK, (K Units), 2015-2020
Table 18. By Application - Thrombolytic Therapy Sales in UK, (K Units), 2021-2026
Table 19. Roche Corporate Summary
Table 20. Roche Thrombolytic Therapy Product Offerings
Table 21. Roche Thrombolytic Therapy Revenue (US$, Mn), (2015-2020)
Table 22. Boehringer Ingelheim Corporate Summary
Table 23. Boehringer Ingelheim Thrombolytic Therapy Product Offerings
Table 24. Boehringer Ingelheim Thrombolytic Therapy Revenue (US$, Mn), (2015-2020)
Table 25. Mochida Pharmaceutical Corporate Summary
Table 26. Mochida Pharmaceutical Thrombolytic Therapy Product Offerings
Table 27. Mochida Pharmaceutical Thrombolytic Therapy Revenue (US$, Mn), (2015-2020)
Table 28. NanJing Nanda Pharmaceutical Corporate Summary
Table 29. NanJing Nanda Pharmaceutical Thrombolytic Therapy Product Offerings
Table 30. NanJing Nanda Pharmaceutical Thrombolytic Therapy Revenue (US$, Mn), (2015-2020)
Table 31. Wanhua Biochem Corporate Summary
Table 32. Wanhua Biochem Thrombolytic Therapy Product Offerings
Table 33. Wanhua Biochem Thrombolytic Therapy Revenue (US$, Mn), (2015-2020)
Table 34. Tianjin Biochem Pharmaceutical Corporate Summary
Table 35. Tianjin Biochem Pharmaceutical Thrombolytic Therapy Product Offerings
Table 36. Tianjin Biochem Pharmaceutical Thrombolytic Therapy Revenue (US$, Mn), (2015-2020)
Table 37. Livzon Pharmaceutical Group Corporate Summary
Table 38. Livzon Pharmaceutical Group Thrombolytic Therapy Product Offerings
Table 39. Livzon Pharmaceutical Group Thrombolytic Therapy Revenue (US$, Mn), (2015-2020)
Table 40. Sedico Pharmaceuticals Corporate Summary
Table 41. Sedico Pharmaceuticals Thrombolytic Therapy Product Offerings
Table 42. Sedico Pharmaceuticals Thrombolytic Therapy Revenue (US$, Mn), (2015-2020)
Table 43. Microbix Corporate Summary
Table 44. Microbix Thrombolytic Therapy Product Offerings
Table 45. Microbix Thrombolytic Therapy Revenue (US$, Mn), (2015-2020)
Table 46. Syner-Med Corporate Summary
Table 47. Syner-Med Thrombolytic Therapy Product Offerings
Table 48. Syner-Med Thrombolytic Therapy Revenue (US$, Mn), (2015-2020)

List Of Figures

LIST OF FIGURES

Figure 1. Thrombolytic Therapy Segment by Type
Figure 2. Thrombolytic Therapy Segment by Application
Figure 3. UK Thrombolytic Therapy Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Thrombolytic Therapy Market Size in UK, (US$, Mn): 2020 VS 2026
Figure 6. UK Thrombolytic Therapy Revenue, 2015-2026 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Thrombolytic Therapy Revenue in 2019
Figure 8. By Type - UK Thrombolytic Therapy Incremental Growth, (US$, Mn), 2015-2026
Figure 9. By Type - UK Thrombolytic Therapy Market Share, 2015-2026
Figure 10. By Application - Thrombolytic Therapy Revenue in UK (US$, Mn), 2020 & 2026
Figure 11. By Application - UK Thrombolytic Therapy Market Share, 2015-2026
Figure 12. PEST Analysis for UK Thrombolytic Therapy Market in 2020
Figure 13. Thrombolytic Therapy Market Opportunities & Trends in UK
Figure 14. Thrombolytic Therapy Market Drivers in UK